ALLERGAN (PRINGY) JUVEDERM VOLUMA WITH LIDOCAINE 1ML; IMPLANT, DERMAL, FOR AESTHETIC USE
|
Back to Search Results |
|
Catalog Number 94151ED |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problem
Vascular System (Circulation), Impaired (2572)
|
Event Date 02/06/2020 |
Event Type
Injury
|
Manufacturer Narrative
|
A review of the device history record has been completed.No deviations or non-conformances noted.The event is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.This is a known potential adverse event addressed in the product labeling.
|
|
Event Description
|
Healthcare professional reported a ¿vascular event¿ and "post injection assessment blanching spot r nasal alar no cap refill" whilst treatment was being injected in the nasolabial folds and "nasal alar" with juvéderm® voluma® with lidocaine.Treatment is noted as "1500iu hylase in 5ml [illegible] nacl, with 30g & bd insulin syringe".Patient was also treated with warm compress, and aspirin.Event has resolved.
|
|
Event Description
|
Healthcare professional reported a ¿vascular event¿ and "post injection assessment blanching spot r nasal alar no cap refill" whilst treatment was being injected in the nasolabial folds and "nasal alar" with juvéderm® voluma® with lidocaine.Treatment is noted as "1500iu hylase in 5ml [illegible] nacl, with 30g & bd insulin syringe".Patient was also treated with warm compress, and aspirin.Event has resolved.
|
|
Manufacturer Narrative
|
Additional, corrected, and/or changed data: b.6., h.6.
|
|
Search Alerts/Recalls
|
|
|